Erdem Cubukcu
Erdem Cubukcu
Prof of Medical Oncology Uludag University
Verified email at
Cited by
Cited by
Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer
YL Wu, M Tsuboi, J He, T John, C Grohe, M Majem, JW Goldman, ...
New England Journal of Medicine, 2020
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally …
D Miles, J Gligorov, F André, D Cameron, A Schneeweiss, C Barrios, B Xu, ...
Annals of Oncology 32 (8), 994-1004, 2021
Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy
AB Şahin, E Cubukcu, B Ocak, A Deligonul, S Oyucu Orhan, S Tolunay, ...
Scientific reports 11 (1), 14662, 2021
Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
A Ulas, N Avci, T Kos, E Cubukcu, OF Olmez, N Bulut, M Degirmenci
lung cancer 18, 20, 2015
Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey
A Ulas, K Silay, S Akinci, D Dede, M AKINCI, M ŞENDUR, E Cubukcu, ...
Asian Pacific Journal of Cancer Prevention 16 (5), 2015
Aurora A overexpression in breast cancer patients induces taxane resistance and results in worse prognosis
Y Cirak, Y Furuncuoglu, O Yapicier, A Aksu, E Cubukcu
J buon 20 (6), 1414-9, 2015
Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer
N Avci, A Deligonul, S Tolunay, E Cubukcu, O Fatih Olmez, A Ulas, ...
J BUON 20 (1), 45-9, 2015
Comparison of three different treatment modalities in the management of cancer cachexia
O Kanat, E Cubukcu, N Avci, F Budak, I Ercan, M Canhoroz, F Olmez
Tumori Journal 99 (2), 229-233, 2013
Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer
M Bayrak, OF Olmez, E Kurt, E Cubukcu, T Evrensel, O Kanat, ...
Clinical and Translational Oncology 15, 307-312, 2013
Türkiye’de meme kanserli hastaların tanı ve tedavi yöntemlerine ulaşım hızı; çok merkezli gözlemsel çalışma
P Saip, S Keskin, M Özkan, MA Kaplan, F Aydoğan, GG Demirağ, ...
The Journal of Breast Health 7 (3), 109-117, 2011
Primary small cell carcinoma of the breast: report of seven cases and review of the literature
O Kanat, S Kilickap, T Korkmaz, BBU Oven, M Canhoroz, E Cubukcu, ...
Tumori Journal 97 (4), 473-478, 2011
The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme
OF Olmez, E Cubukcu, T Evrensel, M Kurt, N Avci, S Tolunay, A Bekar, ...
Clinical and Translational Oncology 16, 173-177, 2014
Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer
E Cubukcu, O Kanat, O Fatih Olmez, S Kabul, M Canhoroz, N Avci, ...
J BUON 18 (2), 359-65, 2013
Biological subtypes and distant relapse pattern in breast cancer patients after curative surgery (Study of Anatolian Society of Medical Oncology)
MA Kaplan, UY Arslan, A Işıkdogan, F Dane, B Oksuzoglu, M Inanc, ...
Breast Care 11 (4), 248-252, 2016
XRCC1 Gene Polymorphisms and Risk of Lung Cancer in Turkish Patients
M Karkucak, T Yakut, T Evrensel, A Deligonul, T Gulten, G Ocakoglu, ...
International Journal of Human Genetics 12 (2), 113-117, 2012
Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients
G Cecener, LS Takanlou, MS Takanlou, U Egeli, GG Eskiler, S Aksoy, ...
Cancer genetics 240, 23-32, 2020
Somatostatin receptor 2 and 5 expressions in gastroenteropancreatic neuroendocrine tumors in Turkey
O Yerci, I Sehitoglu, N Ugras, E Cubukcu, S Yuce, R Bedir, E Cure
Asian Pacific Journal of Cancer Prevention 16 (10), 4377-4381, 2015
Association and prognostic significance of the functional− 1562C/T polymorphism in the promoter region of MMP-9 in Turkish patients with gastric cancer
N Avcı, M Ture, A Deligonul, E Cubukcu, OF Olmez, S Sahinturk, A Topak, ...
Pathology & Oncology Research 21, 1243-1247, 2015
Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy
N Avcı, A Deligönül, S Tolunay, E Cubukcu, ÖF Ölmez, Ö Altmışdörtoğlu, ...
Journal of BU ON., 2015
Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival
A Ulas, T Kos, N Avci, E Cubukcu, OF Olmez, N Bulut, M Degirmenci
Asian Pacific Journal of Cancer Prevention 16 (4), 1643-1649, 2015
The system can't perform the operation now. Try again later.
Articles 1–20